Phase I Study of mPEG-R-Crisantaspase Given IV

Clinical trial NCT01551524 · COMPLETED

Trial details

NCT number: NCT01551524
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2012-03-01
Primary completion: 2015-02-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.